Nandrolone side effects drug for continuous, sequential Pills containing estrogen, take the time. Tablets containing a progestagen is added in a sequential manner within 10 days of each 28 – day cycle.1 should be taken into one tablet once per day, without interruption, preferably at the same time each day. Begin pills containing estradiol (tablet blue) for 12 days, after which for the next 10 days it is necessary to treat estradiol / norethisterone (white tablets) and then for 6 days should be treated with estradiol . During the action phase of red pills occurs regularly separation functional layer of the endometrium. After taking the last pill red treatment continues, taking on the next day the first pill of blue from a new package. Women with amenorrhoea not taking or women with irregular bleeding, or women, translated to continuous therapy combined preparations start treatment at any convenient day. Women switching from another mode sequentialor women still continue the policy serial should be initiated at the 5 th day of the period.Should be prescribed the lowest effective dose for the shortest possible time for the beginning and continuation of treatment of postmenopausal symptoms .
Assigning higher doses of the drug nandrolone side effects combination may be indicated if the response to the reception, after three months of treatment is not sufficient to alleviate the symptoms satisfactory. If the patient has forgotten to take a pill, the pill is not forgotten to be taken. Missed doses can increase the likelihood of resumption of vaginal bleeding and the appearance of smearing vaginal discharge. In all cases, at least 1 time per year to carry out a thorough assessment of risk-benefits and to continue only as long as the benefits of the drug outweigh the risks development of related side effects.
Experience of clinical application For side effects, the most common in clinical studies , include vaginal bleeding and pain / tenderness in the breasts, reported approximately 10% to 20% of patients. Vaginal bleeding usually occurred in the first months of treatment. Breast pain usually disappears after a few months of treatment. All adverse events observed in the randomized clinical trials or similar drugs deca durabolin for sale with greater HRT, compared with placebo, the frequency, and which, by all accounts, possibly associated with HRT are shown below.
Violations of the genital and breast . Very common (> 1/10): pain or tenderness in the breasts, irregular menstruation or menorrhagia often (> 1/100, <1/10): edema or breast enlargement, increase or recurrence of fibroadenoma of the uterus or uterine development of primary fibroadenoma. Uncommon (> 1/1 000; <1/100): endometrial hyperplasia, dysmenorrhea.
Infections and infestations often (> 1/100, <1/10): vaginal candidiasis or vaginitis. Violations of the metabolism and nutrition often (> 1/100, <1/10): fluid nandrolone side effects retention.
Mental disorders often (> 1/100, <1/10): depression or worsening of depression. Uncommon (> 1/1 000; <1/100): nervousness.
Disorders of the nervous system is often (> 1/100, <1/10): headache, migraine or worsening of migraine.
Disorders of the gastrointestinal tract often (> 1/100, <1/10): nausea, abdominal pain, bloating or discomfort in the abdomen. Uncommon (> 1/1 000; <1/100): flatulence or bloating.
Violations of the musculoskeletal and connective tissue often (> 1/100, <1/10): back pain, cramps in the calf muscles. General disorders and administration site in often (> 1/100, <1/10) : peripheral edema, weight gain.
Violations by the immune system Uncommon (> 1/1 000; <1/100): hypersensitivity reactions. Violations by vessels Uncommon (> 1/1 000; <1/100): superficial vein thrombophlebitis. Rare (> 1 / 1 0000; <1/1000): pulmonary embolism, deep vein thrombophlebitis.